>That in general the well being of Native peoples in the US, of African Americans is devalued. It is witnessed in the exclusion in drug trials, in the diseases that pharma considers worthwhile to address...
Speaking about medical research specifically:
You seem to say these outcomes are because of white racists "devaluing" black and native peoples' well-being in an evil act of collective racism.
A simpler explanation would be: There are far fewer blacks and natives than whites in America, which means fewer sick people to help and fewer customers, which means their unique illnesses get less research focus.
The same effect happens between common diseases and rare diseases irrespective of race. Common diseases get studied first, because that's where the most good can be done. This isn't because the well-being of people with rare diseases is "devalued".
Frankly I'm concerned you jump so quickly to a mass accusation of collective racial evil (which echoes historic hatred against other high-performing ethnic groups) when a simpler explanation is so obvious.
Speaking about medical research specifically:
You seem to say these outcomes are because of white racists "devaluing" black and native peoples' well-being in an evil act of collective racism.
A simpler explanation would be: There are far fewer blacks and natives than whites in America, which means fewer sick people to help and fewer customers, which means their unique illnesses get less research focus.
The same effect happens between common diseases and rare diseases irrespective of race. Common diseases get studied first, because that's where the most good can be done. This isn't because the well-being of people with rare diseases is "devalued".
Frankly I'm concerned you jump so quickly to a mass accusation of collective racial evil (which echoes historic hatred against other high-performing ethnic groups) when a simpler explanation is so obvious.